INTERNATIONAL BRAZ J UROL, cilt.44, sa.4, ss.734-739, 2018 (SCI-Expanded)
Purposes: The aim of this study was to determine the diagnostic significance of fibronectin type III domain containing protein 5 (FNDC5)/Irisin levels in the sera of patients with renal cell cancer.